drugset
Drugs / Human Pancreatic Islet Transplantation
last change Dec 2019 re-read 3 minutes ago

Human Pancreatic Islet Transplantation

Cell therapy

Developed for
diabetes mellitus
Investigated by
Bascom Palmer Eye Institute · Diabetes Research Institute Foundation · Midhat H. Abdulreda

Trials 1

today NCT02846571 · Ph 1/2
20202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02846571 Dec 2019 → Dec 2026 expected diabetes mellitus Midhat H. Abdulreda Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Pancreatic Islet Transplantation ClinicalTrials.gov intervention name — accepted as the source's own label NCT02846571 ↗
Modality Cell therapy “the first cellular therapy in T1D” NCT02846571 ↗
Route Other “will be infused into the anterior chamber of the eye through a self-sealing incision in the peripheral cornea” NCT02846571 ↗